XRAY
Dentsply Sirona Inc
Dentsply Sirona Inc historical holders
total: 7
Atlantic Investment Management Dentsply Sirona Inc transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q1
Alex Roepers has been an institutional investor in Dentsply Sirona Inc (XRAY) since 2026 Q1. According to 2026 Q1 report, Alex Roepers holds 610,000 shares with a market value of roughly $7.08M representing 4.12% of their equity portfolio. The fund/company first acquired XRAY in 2026 Q1, initially purchasing 610,000 shares.
Does Alex Roepers still hold XRAY?
Yes, Alex Roepers continues to hold Dentsply Sirona Inc (XRAY). According to their 2026 Q1 report, they maintain a position of 610,000 shares valued at approximately $7.08M, representing 4.12% of their equity portfolio.
When did Alex Roepers first invest in XRAY?
Alex Roepers first invested in Dentsply Sirona Inc (XRAY) in 2026 Q1 at the reported quarter-end price of $11.60 per share, acquiring 610,000 shares in their initial purchase.
What is Alex Roepers's average cost basis for XRAY?
Based on historical transaction data, Alex Roepers's estimated cost basis for Dentsply Sirona Inc (XRAY) is approximately $11.60 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $11.60
XRAY transactions history by Atlantic Investment Management
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
4.12%
|
610,000
|
$11.60
|
$7,076,000
|
new
|
+4.12%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.